IFN-β was not detected in the culture medium (Figure S6D), further experimentally confirming the lower IFN signaling in idMMR neuroblastoma tumors that can negatively impact their MHC class I expression and potential response to anti-PD1 therapy. The gene discussed is IFNB1; the disease is neuroblastoma.